Skip Navigation



European Heart Journal Advance Access published online on November 25, 2008
European Heart Journal, doi:10.1093/eurheartj/ehn522
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
29/24/3061    most recent
ehn522v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Bergman, H.
Right arrow Articles by Verheugt, F. W.A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bergman, H.
Right arrow Articles by Verheugt, F. W.A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2008. For permissions please email: journals.permissions@oxfordjournals.org

Hotline sessions of the 30th European Congress of Cardiology

Heidi Bergman{dagger}, Annemieke M. Rolink{dagger} and Freek W.A. Verheugt*

Department of Cardiology, Heartlungcenter, University Medical Center, St Radboud, Nijmegen, The Netherlands

Received 27 October 2008; revised 28 October 2008; .

* Corresponding author. Tel: +31 2436 14220, Fax: +31 2435 40537, Email: f.verheugt@cardio.umcn.nl, f.w.a.verheugt@cardio.umcn.nl

Key Words: European Society of Cardiology • Congress • Highlights

The first 150 words of the full text of this article appear below.

Of the 16 presentations at the three Hotline sessions of the 30th European Congress of Cardiology, held in Munich, Germany, 30 August–3 September 2008, nine are summarized below, since the others have already been published (BEAUTIFUL, Lancet 2008; 372; 807–821; TRANSCEND, Lancet 2008: 372; 1174–1183; GISSI-HF (n-3-PUFA), Lancet 2008 (Epub ahead of print); GISSI-HF (rosuvastatin), Lancet 2008 (Epub ahead of print); LEADERS, Lancet 2008: 372; 1163–1173; IBIS 2, Circulation 2008: 118; 1172–1182; SEAS, N Engl J Med 2008 (Epub ahead of print). The authors of this summary collected the information given during the presentations of the studies, as well as from press releases prepared by most speakers. This report shows only preliminary results.

During the first Hotline Session, five studies on the medical treatment of heart failure (HF) were presented. Since three of these trials have already been published, only two of . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Eur Heart JHome page
D. Atar
Hotline sessions of the 30th European Congress of Cardiology
Eur. Heart J., May 1, 2009; 30(9): 1151 - 1151.
[Full Text] [PDF]